Shenzhen Bioeasy Biotechnology Co. Ltd. (300942) — Capital Reinvestment Ratio
Shenzhen Bioeasy Biotechnology Co. Ltd. (300942) has a Capital Reinvestment Ratio of 1.27x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥9.12 Million) in capital expenditures (CN¥11.62 Million). See Shenzhen Bioeasy Biotechnology Co. Ltd. free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Shenzhen Bioeasy Biotechnology Co. Ltd. Capital Reinvestment Ratio (2016–2025)
This chart tracks Shenzhen Bioeasy Biotechnology Co. Ltd.'s Capital Reinvestment Ratio across 9 annual periods.
Annual Capital Reinvestment Ratio for Shenzhen Bioeasy Biotechnology Co. Ltd. (2016–2025)
Year-by-year Capital Reinvestment Ratio for Shenzhen Bioeasy Biotechnology Co. Ltd. from 2016 to 2025. For live market cap and broader valuation context, see 300942 market cap overview.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.69x | CN¥66.87 Million | CN¥45.90 Million | ▼ -86.5% |
| 2024 | 5.08x | CN¥34.26 Million | CN¥174.10 Million | ▲ +338.4% |
| 2022 | 1.16x | CN¥152.55 Million | CN¥176.85 Million | ▲ +272.4% |
| 2021 | 0.31x | CN¥255.42 Million | CN¥79.51 Million | ▼ -76.0% |
| 2020 | 1.30x | CN¥63.79 Million | CN¥82.84 Million | ▲ +232.1% |
| 2019 | 0.39x | CN¥67.24 Million | CN¥26.29 Million | ▲ +115.1% |
| 2018 | 0.18x | CN¥57.93 Million | CN¥10.53 Million | ▼ -60.3% |
| 2017 | 0.46x | CN¥23.60 Million | CN¥10.82 Million | ▲ +84.4% |
| 2016 | 0.25x | CN¥36.31 Million | CN¥9.03 Million | — |